Approvals/TGA/ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack

Approved

STANDARD

ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack

Hetero Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6aca3f2e37688cc2
Product Name: ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack
Artg Id: 297922
Artg Name: ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack
Sponsor: Hetero Australia Pty Ltd
Company Detail Path: /organization/hetero-australia-pty-ltd
Artg Date: 2022-12-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d6668a2a89f7689d1c0244aa9ae089e8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6aca3f2e37688cc2

Type

Standard